Cook Medical Archives - Medical Design Sourcing

Cooper Companies spends $300M on some Cook Medical product lines

Cook Medical today agreed to sell some reproductive health and otolaryngology product lines to Cooper Cos., the companies announced.

The purchase price was $300 million. The products in the sale represent about 2.5% of Cook Medical’s sales. Manufacturing will get transferred to Cooper Cos. over a two-year period.

The news comes about three months after the Federal Trade Commission announced that the companies had abandoned a proposed $875 million acquisition of the Cook Medical Reproductive Health business. The FTC had investigated whether the previous deal was anti-competitive.

The new deal includes select products from Cook Medical’s maternal fetal medicine portfolio — as well as gynecological surgery products, Doppler monitor technology, disposable devices, and accessories.

“This acquisition is an excellent strategic fit for CooperSurgical,” CooperSurgical President Holly Sheffield said in a news release. “We’re adding highly synergistic …

Cook Medical wins Vizient’s supplier of the year award

Cook Medical announced on Tuesday that it won the 2023 Vizient Supply Assurance Supplier of the Year Award.

The company received the award at the 2023 Vizient Connections Summit. It said the award demonstrates its transparency and commitment to communication during the supply chain process.

Vizient’s award goes to a company that demonstrates flexibility, innovation and distinction in ensuring the uninterrupted supply of products. These suppliers also have active and comprehensive participation in Vizient’s supply assurance programs or initiatives.

“The last several years have shown massive shifts in supply chain for industries all over the world. This award is an honor to get at any time, but considering the pandemic and many other factors, this award is especially meaningful,” said Ross Harvey, Cook’s VP of global supply chain. “We can’t control everything that goes on in the world, but we can focus on the things we have control over. We can…

Cooper Companies abandons $875M Cook Medical Reproductive Health business acquisition

The FTC issued a statement announcing that it learned that the Cooper Companies terminated its planned acquisition of a Cook Medical business.

In February 2022, Cook Medical signed a letter of intent to sell its Reproductive Health business to CooperCompanies. The deal totaled $875 million. Cooper agreed to pay $675 million at closing and the remaining $200 million in four $50 million annual installments.

Cook Medical’s Reproductive Health business developed products for obstetrics and gynecology, in vitro fertilization (IVF) and assisted reproductive technology (ART).  That includes developing the first needle specifically for IVF treatments, the company previously said.

The companies anticipated the closing of the deal could come as soon as the second quarter of 2022. However, the FTC launched an investigation to determine whether the deal was potentially anti-competitive.

Upon learning of the decision to terminate the acquisition, FTC Bur…

Cook Medical gets FDA nod for endovascular graft trial for treating aortic aneurysm

The Zenith Fenestrated AAA Endovascular Graft. [Image from the Cook Medical website]Cook Medical received FDA approval to initiate an investigational device exemption (IDE) study for an aortic aneurysm treatment.

The study will evaluate the Zenith Fenestrated + Endovascular Graft (ZFEN+). It assesses the safety and effectiveness of ZFEN+ in combination with Bentley’s InnoMed BeGraft balloon-expandable Fevar bridging stent graft system. The companies aim to look at the treatment of aortic aneurysms involving one or more of the major visceral arteries.

ZFEN+ remains predicated on the commercially available Zenith Fenestrated AAA Endovascular Graft. However, it extends the proximal margin of aneurysmal disease for endovascular treatment. This includes patients with more complex aortic disease. Currently, only open surgical repair stands as an option for treating complex aortic disease, Cook Medical said.

“Outside the United States, Bentley has supplied 3…

Cook Medical is laying off 500 workers amid strategic realignment

Cook Medical announced today that it will lay off 500 workers — about 4% of its global workforce.

In a message to employees posted on the Bloomington, Indiana–based medtech company’s website, Cook Medical President Pete Yonkman described the layoffs as the “most difficult decision we have had to make in support of our strategy.”

“The last several years have brought significant change to our customers, our supply chain, and the way we work,” Yonkman said. “To ensure that we are positioned to be successful in this new world, our global leadership teams have implemented a new five-year vision and strategic plan that were informed by extensive feedback from our customers, employees, and leadership teams.”

Impacted employees inside the U.S. will receive an email between 8 and 9 a.m. Eastern time tomorrow. Yonkman said senior leadership outside the U.S. would make sure employees would be notified as quickly as possible…

Cook Medical treats first patients with venous valve

Cook Medical today announced the first patient treated in a study evaluating its new venous valve for treating chronic venous insufficiency.

Dr. Mauricio Alviar, a principal investigator, treated the first patient in the clinical study. Alviar serves as a vascular surgeon at Clinica de la Costa in Barranquilla, Colombia. Deployment took a few minutes, Alviar noted, and the patient had local anesthesia.

Bloomington, Indiana-based Cook Medical said it’s now testing the valve’s safety and efficacy in a global, multi-site clinical trial. Dr. Paul Gagne of Vascular Care Connecticut serves as global principal investigator. This trial evaluates the safety, efficacy, wound healing, leg pain and disability levels over five years.

“When leg veins function poorly, patients suffer with leg swelling, leg pain, leg ulcers, disability, and possible amputation,” Gagne said. “Therefore, it is important to restore blood flow out of the leg veins, b…

Cook Medical launches urological bipolar electrodes porfolio

The urological bipolar electrodes are for daily use in bladder and prostate procedure. [Image courtesy of Cook Medical]

Cook Medical announced today that it has launched a streamlined portfolio of urological bipolar electrodes in the U.S.

The electrodes are for daily use in bladder and prostate procedures. The new portfolio includes seven products. Six have configurations for use in transurethral resection, ablation and soft tissue removal of the prostate and bladder, and where hemostasis is required.

The products include:

A bipolar transurethral bladder loop, angled at 136° to accommodate the anatomy of the bladder; Four transurethral cutting loops — 12° and 30° options — each available in medium and large sizes; A bipolar transurethral needle electrode

The seventh product is the Bipolar Transurethral Plasma Disc. The Bipolar Transurethral Plasma Disc’s creators made …

6 drug delivery innovations you need to know

From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops.

Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies.

More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some updates on some of those technologies, plus introductions to others, here are some more impressive developments you should keep an eye on:

1. Needle-free delivery

Vaccines have become a major talking point over the past couple of years amid the COVID-19 pandemic and a number of companies are working on ways to deliver them, as well as other forms of medication, through different avenues.

A major speed bump in vaccine hesitancy can be fear of needles, so the introduction of needle-free drug delivery could make big waves in the space.

Two companies pushing forward with …

Cook Medical makes next-gen in vitro fertilization incubator available in U.S., Canada

[Image from Cook Medical]Cook Medical announced today that it launched the next-generation MINC+ benchtop incubator in the U.S. and Canada.

Bloomington, Indiana-based Cook Medical designed its MINC+ platform as the latest iteration of the MINC mini incubator benchtop system that has been in in-vitro fertilization (IVF) clinics for more than two decades.

The latest version of MINC includes the DishTrace platform designed to combine functionality through the incubator touchscreen and a PC software program for a wide array of dish-data management tools, according to a news release.

With DishTrace, users can access and log information through the system’s touchscreen, track culture dishes as they are checked in and out of incubator, monitor up to 50 MINC+ incubators and generate and view graphical histories and reports of MINC+ activity, Cook Medical said.

“We listened to user feedback when…

Cook Medical wins FDA breakthrough designation for Thoraco+ endovascular system

Cook Medical today announced that its Zenith Thoraco+ endovascular system received FDA breakthrough device designation.

Thoraco+ is the company’s next-generation endovascular graft that is indicated for the endovascular treatment of patients with thoracoabdominal aortic aneurysms.

Get the full story on our sister site, Medical Tubing + Extrusion.

CooperCompanies buys Cook Medical’s reproductive health business for $875M

Cook Medical announced today that it has signed a letter of intent to sell its Reproductive Health business to CooperCompanies.

CooperCompanies (NYSE:COO) plans to pay privately-held Cook Medical $875 million — $675 million at closing, with the remaining $200 million paid in four $50 million annual installments.

The proposed deal is subject to applicable local consultation obligations and regulatory approvals.

For more than 40 years, Cook focused on Reproductive Health. Over the decades, it developed products for obstetrics and gynecology, in vitro fertilization (IVF) and assisted reproductive technology (ART).  The company’s work included developing the first needle specifically for IVF treatments.

“Our history with reproductive health has been full of innovations to help patients fulfill their dreams of having a family,” D.J. Sirota, SVP of Cook Medical’s MedSurg specialty, said in a news release.

“This agreement represents more tha…

Cook Medical wins FDA breakthrough designation for new drug-eluting stent

Cook Medical recently announced that it received FDA breakthrough designation for its drug-eluting stent for below the knee.

Bloomington, Indiana-based Cook Medical designed the stent to treat patients who have chronic limb-threatening ischemia (CLTI).

Get the full story on our sister site, Medical Tubing + Extrusion.